Skip to main content
Caplight Logo









Kinergizer

Kinergizer

Private
DelftFrontier & Industrial Techhttps://kinergizer.com

Last Round

Seed

May 1, 2024

Total Funding Raised

$1.62M

Company Overview

Kinergizer operates in Frontier & Industrial Tech and is based in Delft. Its latest recorded funding round was a Seed round in May 2024.

Kinergizer is an industrial technology company that designs and manufactures motion energy harvesting solutions for wireless IoT sensors.

Sector

Frontier & Industrial Tech

Verticals

IoT Hardware, Sensors, Energy Storage

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Kinergizer Comparables

Compare Kinergizer with similar companies based on industry and business-model similarity.

Kinergizer comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Viezo
87%
ReVibe Energy
85%
Xidas
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Kinergizer Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Kinergizer Investors

Notable investors and investment history

Kinergizer investors
InvestorRounds
FORWARD.oneSeed
East Netherlands Development Agency (Oost NL)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 16, 2024

    Monthly visitors grew 493% MoM, reaching 794.

  • May 1, 2024

    $1.6M round led by FORWARD.one and Oost NL.

Book a demo to see all signals

For institutional investors. Book with your work email.

Kinergizer Filings

Explore SEC and related filing metadata, where available.

Kinergizer filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Kinergizer's valuation, stock price, and market status.

Is Kinergizer a public or private company?

Kinergizer is a private company.

What is the current stock price of Kinergizer?

Kinergizer is a private company, so its shares have no public market price. Caplight tracks Kinergizer's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Kinergizer worth (valuation)?

Valuation information for Kinergizer is not publicly available.

Can I buy Kinergizer stock?

Kinergizer shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Kinergizer's last funding round?

Kinergizer's most recent funding round was Seed on May 1, 2024.

Who are the main investors in Kinergizer?

Key investors in Kinergizer include FORWARD.one, East Netherlands Development Agency (Oost NL).

Will Kinergizer IPO soon?

No public IPO plans have been announced for Kinergizer.

How can I track Kinergizer secondary market activity?

Caplight tracks bids, offers, and trades in Kinergizer's shares on secondary markets.

Firmographic Details

HeadquartersDelft
Employee Range4
Year Founded2012
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?